Castle Connoly named Dr. Eva Feldman an "Exceptional Women in Medicine" for the fifth year in a row due to her contributions to the advancement of healthcare through clinical care, research, community service, education, and leadership.
November 14 is World Diabetes Day and the theme for 2021 is "Diabetes Cares: If Not Now Then When?" One aspect of diabetes care is access to a healthy diet and physical activity. The groundbreaking research of our diabetes team at the NeuroNetwork of Emerging Therapies is proving more and more why this is so important.
To celebrate World Diabetes Day and 100 years of insulin, Disease Models & Mechanisms published an examination of current diet-induced rodent models of peripheral neuropathy, a severe complication of type 2 diabetes.
It has been 100 years since the discovery of insulin. To celebrate this centenary, Disease Models & Mechanisms explores ongoing research in diabetes, including three publications from Drs. Eva Feldman, Stephanie Eid, Sarah Elzinga, and former lab member Dr. Phillip O'Brien.
On small fiber neuropathy: "Doctors, and especially neurologists, are more aware of this condition than they were 10 years ago," said Dr. Brian Callaghan, an associate professor of neurology at the University of Michigan Medical School in Ann Arbor. Callaghan co-wrote an editorial accompanying the new study.
Deanna Lites speaks to Dr. Goutman about why it's important to look at environmental factors in ALS, which will be part of the new ALS medical moonshot thanks to a $3.6 million grant from the NIH.
"We’ve had multi-millions of cases of COVID in this country. I mean let’s do the math, when 20 percent of those individuals – we’re talking about millions of individuals who have long COVID, those individuals are really impaired." Dr. Eva Feldman speaks to One Detroit's Bill Kubota on Detroit Public Television about Long COVID.
The American Neurological Association (ANA) honored Dr. Eva Feldman with the 2021 Raymond D. Adams Lectureship at their annual meeting.
"I don't know of one person in Ann Arbor who has individually done more in the fight against ALS than (Dr.) Bob Schoeni." Dr. Eva Feldman remembers her friend, colleague and ALS ally in a moving letter.
A multidisciplinary group of University of Michigan researchers will investigate environmental exposures, chosen as one of the first projects in a new National Institutes of Health amyotrophic lateral sclerosis initiative.
Associate Professor Benjamin Murdock, Ph.D., speaks about the immune system and ALS on the podcase for the Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) Consortium.
A CDC-funded multidisciplinary effort at U-M will investigate air pollution as a major and modifiable risk factor for ALS and seek to identify therapy targets.
In a recent publication, Dr. Brian Callaghan looks at how the approach of approving drug therapies differs between the United State and the United Kingdom.
The National ALS Registry, managed by the Center for Disease Control (CDC) is one of the most important weapons in the fight against Amyotrophic Lateral Sclerosis (ALS). At the Annual Surveillance Meeting, Pranger ALS Clinic Director Dr. Stephen Goutman presented an update of important findings funded by the CDC.
At the 31st Annual Meeting of NEURODIAB, Dr. Stephanie Eid was awarded the Angelika Bierhaus prize in basic research .
In honor of World Brain Day, established by the World Federation of Neurology, we wanted to share a selection of brain imaging from our research.
Speaking to the joint Harvard NeuroDiscovery Center and MassGeneral Institute for Neurodegenerative Disease Informatics group, Dr. Feldman discusses the problem of diabetic neuropathy, its causes and treatment, and our lab investigations of this condition.
Dr. Brian Callaghan shares his position about the current problems of diabetic neuropathy testing. He presented this argument during a debate at the American Diabetes Association's 81st Scientific Sessions.
Our collaborator in science Dr. Sunitha Nagrath shares her experiences and advice as a female engineer, from her beginnings in India to her work with us uncovering the secrets of exosomes.
Ever heard of a runner's high? The fourth installment of the NeuroNetwork for Emerging Therapies Mini Symposium Series explores the effects of exercise on the nervous system and brain health.
